Stocks to buy

May has brought attention to seven penny stocks that investors should consider adding to their portfolios. As a keen observer of the cryptocurrency market, I’ve been watching Bitcoin (BTC-USD) closely as it aims to reach new all-time highs. However, I’ve also been keeping an eye on some fascinating penny stocks that I believe offer significant

Penny stocks are on the riskier end of the public equity spectrum. They are characterized by their low volume, affordable pricing, and the rapid pace at which their values can surge or plummet compared to more traditional stocks. But, for well-informed investors, penny stocks offer a chance to secure substantial gains on the cheap. When

For the past several weeks, stocks have been caught in rough waters. After the most recent batch of hotter-than-expected inflation data sent investors spiraling into panic mode, Federal Reserve rate-cut hopes evaporated. Yields rocketed; and stocks dropped. In fact, Wall Street has been holding its breath since that data’s release, eagerly awaiting the Fed’s next

The Dow Jones Industrial Average has been around since 1885. The index contains 30 stocks and has regularly added and removed holdings from the list. An index with 30 stocks has more concentration than indices like the S&P 500 and the Nasdaq 100, which spread their assets across more holdings. However, some Dow stocks to buy are better than others. Investors must

Healthcare stocks certainly haven’t set the world on fire lately. The S&P Health Care Index is up 3% so far in 2024 compared to an 8% gain in the benchmark S&P 500. Yet, many leading healthcare companies just issued better-than-expected financial results for this year’s first quarter. Additionally, these stocks tend to perform well during

Wedbush Securities has a solid track record with many publicly traded companies it covers. Over the past few months, the investment firm hiked its price target on several intriguing companies, many of which may prove great buys after the recent wave of market volatility. Of course, investors shouldn’t treat any analyst rating and price targets

Biotech stocks are full of intriguing innovators who could help pave the way for greater gains over the years ahead. Undoubtedly, it’s virtually impossible to tell exactly which pills, shots and treatments within a firm’s pipeline will eventually evolve into cash flows, let alone blockbuster cash cows. With many clinical trials to pass, even a

Not every stock crashes with the rest of the market. Some corporations offer high margins of safety and can hold firmly during bad times. Putting some of your capital in these investments can reduce your portfolio’s losses from peak to trough.  However, a small number of stocks can actually perform well when the market crashes. It’s harder to find

While a weakening economy and a subsequent dip in the stock market are unfortunate, they are inevitabilities. Even booming segments like the biotech sector are not immune to the general trend of recessions that Western economies experienced over the last 40 years or so. These downturns, however, provide opportunities for investors to buy stocks at

Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks. Each exhibits unique approaches and accomplishments in biotechnology, healthcare services, and pharmaceuticals. Solid product leads, especially in the U.S. market, have propelled the first company’s biosimilar industry to an astounding rise.

Alphabet’s (NASDAQ:GOOG, NASDAQ:GOOGL) Gemini AI has once again been overtaken by other models, but it remains one of the best choices out there for AI stock predictions. Bard (the company’s model preceding Gemini) was previously ranked by analysts as the best AI tool for stock picking, even outperforming human stock pickers a test run. However, Gemini has

The average investor probably appreciates no-hassle investments more than anything else. Most investors simply want to set it and forget it when it comes to their portfolio. Far fewer investors are willing or capable of spending their time tethered to trading stations in an attempt to find Alpha. That’s part of the reason blue-chip stocks

When the going gets tough, the tough buy blue chip stocks. That’s because they are safe havens in times of turmoil. These are large companies with a proven track record of success and profits that have sterling financial statements. That means when markets go south, they will continue standing tall. The following three blue chip

It’s not all fun and games when it comes to the market’s top spatial computing (or metaverse) stocks. Undoubtedly, we’ve seen some pretty capable mixed-reality headsets launching in recent years. And with the launch of Apple (NASDAQ:AAPL) Vision Pro, it seems like mixed reality isn’t all too far off from making its mark on the

Once a Wall Street darling, Netflix (NASDAQ:NFLX) is now considered a left-behind as the market obsesses over Magnificent Seven stocks. Nowadays, positive earnings results aren’t enough to get investors enthused about Netflix stock. Yet, today you can be a leader instead of a follower. I invite you to contravene the crowd, embrace change and build a

Few investment strategies have performed as well for as long as dividend investing. Numerous studies show that buying stocks that have initiated a dividend and then increased it over time beat all other stocks on the market. That’s why Dividend Aristocrat stocks are the cream of the crop. To become dividend royalty, companies need to

The Federal Reserve is not purposefully trying to crash the economy, but it might end up doing so anyway. Because out-of-hand government spending reignited inflation’s rise, the Fed is no longer eager to cut sky-high interest rates. It’s even being whispered the central bank could even raise rates again. Threading the needle between interest rates,

UBS says investors should forget about the Magnificent Seven and look across the Atlantic to 18 European stocks they’ve highlighted that account for approximately 25% of the Stoxx Europe 600 Index, the exact weighting as the Mag 7 when initially conceived in 2023.  At least with the Mag 18, you have 18 choices rather than

Speculation is rife in the market right now and there are plenty of risky stocks for investors to gamble on in an attempt to make a fortune. This is especially true as the market for initial public offerings (IPOs) has returned after two difficult years for new stock issuance. According to data from EY, the

While I have written quite a few articles lately on shifting some of your gains into defensive stocks and safe dividend stocks, I still think that it is very important to keep some potential multibagger growth stocks in your portfolio. No one truly knows where the market is headed. We may even see the rally